Giant Biogene
a Hong Kong-listed recombinant-collagen producer behind the consumer brand Kefumei (可复美), which had its second recombinant-collagen implant medical device approved in China in 2026, extending beyond topical cosmetics into medical aesthetics.
- Country
- China
recombinant-collagen
cn
Coverage
| CN | EU | US | |
|---|---|---|---|
| fibers-textiles | ✓ | ✓ | ✓ |
| specialty-fine-chem | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpareach
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Cosmetics, nutricosmetics & wellness | specialty-fine-chem | Low | → |
| Recombinant collagen for cosmetics | fibers-textiles | Medium | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.